Table 1.
Patients’ Cohort (n = 162 Patients) | |
---|---|
Feature | Median (Range)-# (%) |
Age (years) | 62 (39–82) |
Sex | |
Male | 100 (61.7%) |
Female | 62 (38.3%) |
BMI (kg/m2) | 25.4 (18.0–40.3) |
Number of liver metastases per patient | 2 (1–5) |
Size of liver metastases (mm) | 32 (10–71) |
Preoperative chemotherapy | 124 (76.5%) |
>6 cycles | 69 (42.6%) |
Interval between CT and surgery (days) | 23 (1–65) |
VOIs | |
Number of analyzed Tumor VOIs | 409 |
Volume of metastases (mL, Tumor VOI) | 4.1 (0.55–380) |
Number of analyzed Margin VOIs | 409 |
Volume of Margin VOI (mL) | 9.6 (3.4–107.2) |
Number of analyzed Liver VOIs | 162 |
Volume of Liver VOI (mL) | 1.96 (fixed value) |
BMI: Body mass index; CT: Computed tomography; VOI: Volume of interest.